Workflow
亚太药业:注射用阿昔洛韦通过仿制药一致性评价

Core Viewpoint - The company has successfully passed the consistency evaluation for its injectable Acyclovir, enhancing its product pipeline and market competitiveness while gaining experience for future evaluations [1] Group 1: Product Development - The injectable Acyclovir is indicated for the treatment of herpes simplex virus infections, shingles, and chickenpox in immunocompromised patients [1] - The approval of the consistency evaluation will enrich the company's product line [1] Group 2: Market Position - The successful evaluation is expected to improve the company's market competitiveness [1] - The experience gained from this evaluation will facilitate the consistency evaluation of other products in the future [1]